US FDA Ends 2019 With Second-Highest Approval Count After Second-Half Rebound

 
• By Michael Cipriano
  
Pink Sheet Perspectives 2019 to 2020
CDER Approved 48 novel agents in 2019, the second highest total of the contemporary FDA.

More from Approvals

More from Product Reviews